Literature DB >> 10767921

Coagulation studies in patients admitted with epistaxis--current practice in Scotland.

S Holland1, M A Thaha, E L Nilssen, P S White.   

Abstract

Epistaxis remains the most common ENT emergency. The use of coagulation studies in Scotland to manage these patients was investigated to determine current practice. The study took the form of a postal questionnaire sent to all practising ENT consultants and a telephone survey of ENT senior house officers working in Scotland. Of the 60 questionnaires circulated amongst consultants, 55 responses were received (92 per cent). Thirty-eight consultants (70 per cent) indicated that they did not routinely request a coagulation screen for their patients, however, 30 per cent (16) did. Forty-three of the 45 junior staff were available for interview, 22 (51 per cent) of whom routinely requested coagulation studies. While the majority of consultants did not request routine coagulation studies, there did not appear to be any consensus among the junior staff. Although there is a paucity of scientific information with regard to this aspect of epistaxis patient management, there is support in the literature for targeted rather than blanket testing. There is perhaps a need to address this issue within individual departments, to achieve uniformity of practice, and to improve communication between junior and senior staff.

Entities:  

Mesh:

Year:  1999        PMID: 10767921     DOI: 10.1017/s0022215100157950

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Routine clotting screen has no role in the management of epistaxis: reiterating the point.

Authors:  M Shakeel; A Trinidade; T Iddamalgoda; M Supriya; K W Ah-See
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-04-09       Impact factor: 2.503

2.  Role of routine coagulation studies in idiopathic epistaxis.

Authors:  N M Pande; S K T Jain; D M Mahore; A Z Nitnaware; B D Bokare; P T Sakhare
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.